FDA Webinar: Project Facilitate: Oncology Expanded Access Program Update
The U.S. Food & Drug Administration’s (FDA’s) Division of Drug Information in the Center for Drug Evaluation and Research is hosting a free, one-hour educational webinar on its Expanded Access Program on December 14, 2020 at 1:00 p.m. ET.
Expanded Access is the regulatory pathway by which an oncologist may obtain access to an investigational drug product for the purposes of treating a patient with a life-threatening medical condition for which there is no acceptable treatment.
Learning Objectives:
- Define expanded access and the key requirements for an expanded access request for an individual patient.
- Summarize the key responsibilities of the oncology healthcare professional when considering expanded access for a patient.
- Identify resources available to healthcare professionals considering submission of an oncology expanded access request for an individual patient.
- Describe how Project Facilitate is a resource to navigate the oncology Expanded Access pathway.
This virtual event is part of a series of webinars designed to help health care professionals and students provide better care by knowing how to find relevant FDA regulatory information that will improve drug safety. Learn more about the series.
Click here to register for the December 14 webinar.
